Connection

Andy Goren to Androgens

This is a "connection" page, showing publications Andy Goren has written about Androgens.
Connection Strength

2.933
  1. Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals. J Am Acad Dermatol. 2020 12; 83(6):e401-e402.
    View in: PubMed
    Score: 0.682
  2. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign". J Am Acad Dermatol. 2020 Aug; 83(2):680-682.
    View in: PubMed
    Score: 0.668
  3. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020 Jul; 19(7):1545-1547.
    View in: PubMed
    Score: 0.664
  4. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020 Jul; 83(1):308-309.
    View in: PubMed
    Score: 0.663
  5. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Med Hypotheses. 2020 Oct; 143:110112.
    View in: PubMed
    Score: 0.169
  6. Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism. Int J Dermatol. 2021 Jul; 60(7):e267-e268.
    View in: PubMed
    Score: 0.044
  7. Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed. Dermatol Ther. 2020 11; 33(6):e14166.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.